Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.278,61
-5,48%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE AbbVie Inc (ABBV) AbbVie Inc (ABBV) Notizie

ABBV

AbbVie (ABBV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ABBV
DataOraFonteTitoloSimboloCompagnia
26/04/202413:47IH Market NewsU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and Upcoming Inflation DataNYSE:ABBVAbbVie Inc
26/04/202413:35PR Newswire (US)AbbVie Reports First-Quarter 2024 Financial ResultsNYSE:ABBVAbbVie Inc
25/04/202414:00PR Newswire (US)New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis StudyNYSE:ABBVAbbVie Inc
23/04/202414:00PR Newswire (US)Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest BrandsNYSE:ABBVAbbVie Inc
18/04/202414:31PR Newswire (US)Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell ArteritisNYSE:ABBVAbbVie Inc
12/04/202413:30PR Newswire (US)AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of MigraineNYSE:ABBVAbbVie Inc
09/04/202414:00PR Newswire (US)SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to AcneNYSE:ABBVAbbVie Inc
04/04/202414:00PR Newswire (US)AbbVie to Host First-Quarter 2024 Earnings Conference CallNYSE:ABBVAbbVie Inc
03/04/202414:30PR Newswire (US)Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting®NYSE:ABBVAbbVie Inc
01/04/202413:50GlobeNewswire Inc.NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-YearNYSE:ABBVAbbVie Inc
26/03/202412:20IH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNYSE:ABBVAbbVie Inc
25/03/202416:00PR Newswire (US)Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in AestheticsNYSE:ABBVAbbVie Inc
25/03/202413:31PR Newswire (US)AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesNYSE:ABBVAbbVie Inc
22/03/202420:02PR Newswire (US)U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer PatientsNYSE:ABBVAbbVie Inc
21/03/202413:00PR Newswire (US)ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024NYSE:ABBVAbbVie Inc
07/03/202414:00PR Newswire (US)AbbVie to Present at the Barclays 26th Annual Global Healthcare ConferenceNYSE:ABBVAbbVie Inc
06/03/202414:03PR Newswire (US)AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics PortfoliosNYSE:ABBVAbbVie Inc
05/03/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
05/03/202418:09PR Newswire (Canada)Dragonfly a reçu un paiement d'étape à la suite de la prise de dose du premier patient à l'essai clinique de phase 1 d'AbbVie évaluant le DF4101/ABBV-303NYSE:ABBVAbbVie Inc
05/03/202414:00PR Newswire (US)JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA ApprovalNYSE:ABBVAbbVie Inc
05/03/202413:00PR Newswire (US)Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303NYSE:ABBVAbbVie Inc
02/03/202401:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
28/02/202406:05PR Newswire (US)AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic InflammationNYSE:ABBVAbbVie Inc
27/02/202414:00GlobeNewswire Inc.Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South KoreaNYSE:ABBVAbbVie Inc
27/02/202414:00PR Newswire (US)AbbVie to Present at the TD Cowen 44th Annual Health Care ConferenceNYSE:ABBVAbbVie Inc
27/02/202413:45PR Newswire (US)U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)NYSE:ABBVAbbVie Inc
26/02/202423:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABBVAbbVie Inc
26/02/202412:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ABBVAbbVie Inc
22/02/202414:05PR Newswire (US)AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and ImmunologyNYSE:ABBVAbbVie Inc
21/02/202414:00PR Newswire (US)BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women EntrepreneursNYSE:ABBVAbbVie Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ABBV

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network